Page 16 - Angle Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Angle flags potential delay in US clearance for Parsotix after FDA issues further information request | 4 March 2021

4 March 2021 | 10:11am StockMarketWire.com - Liquid biopsy company Angle said it was likely that US clearance for Parsortix would occur later than initially expected after the company received a request to supply further information from the US Food and Drug Administration. The company said it was likely clearance would occur in the second half of 2021 rather than the previous guidance of the earliest prospect of FDA clearance being Q2 CY21 . Some of the technical information requested necessitates some targeted additional analytical studies, it added. However, these additional analytical studies do not require patient samples and ANGLE anticipates that the necessary studies, which are already at an advanced planning stage, can be completed and the response submitted by early May.

Drug administrationAngle plcLon aglAgl lகோணம் ப்ல்

Investegate |Angle PLC Announcements | Angle PLC: Parsortix-harvested CTCs uncover novel biomarker

About ANGLE plc www.angleplc.com ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. ANGLE s proven patent protected platforms include a circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins. ANGLE s cell separation technology is called the Parsortix ® system, and it enables a liquid biopsy (a simple blood test) to be used to provide the cells of interest to the user in a format suitable for multiple types of downstream analyses. The system is based on a microfluidic device that captures cells based on a combination of their size and compressibility. The system is epitope independent and can capture all types of CTCs as well as CTC clusters in a viable form (alive). CTCs enable the complete picture of a cancer to be seen as being an intact cell they allow DNA, RNA and protein analy

Nordrhein westfalenUnited statesCarl holmesCiara martinSimon hicksTeddy whileyAndrew craigAndrew newlandNigel barnesNigel birksIan griffithsSimon conwayChris leeCap ltdUniversity medical centre hamburgUniversity medical centre hamburg eppendorf

Investegate |Angle PLC Announcements | Angle PLC: Parsortix demonstrates high capture rate of CTCs

CANCER-ID was a European consortium funded by the Innovative Medicines Initiative (IMI) aimed at the establishment of standard protocols for and clinical validation of blood-based biomarkers. It brought together experts from academic and clinical research, innovative Small-to-Medium sized Enterprises (SMEs), diagnostics companies and the pharmaceutical industry thus providing a unique setting for establishing clinical utility of liquid biopsies . About ANGLE plc www.angleplc.com ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. ANGLE s proven patent protected platforms include a circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.

United statesNikolas stoeckleinCarl holmesCiara martinSimon hicksTeddy whileyAndrew craigAndrew newlandNigel barnesNigel birksIan griffithsSimon conwayChris leeCap ltdEuropean liquid biopsy societyEnterprises smes

Cancer Biopsy Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027

Cancer Biopsy Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSouth koreaAsia pacificAngle plcMarket analysts at futurewise researchGuardant healthGrail incFuturewise market researchFreenome holdings incHologic incRoche ltdBiocept incResearch methodologyCompany profilesIllumina inc

Liquid Biopsy Market Size 2020 | Top Companies are Qiagen, Adaptive Biotechnologies, Johnson & Johnson, Angle Plc , Biocept Inc

Liquid Biopsy Market Size 2020 | Top Companies are Qiagen, Adaptive Biotechnologies, Johnson & Johnson, Angle Plc , Biocept Inc
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomAsia pacificNatera incAngle plcBrand essence market researchSysmex corporationPathway genomics corporationGuardant health incInternational agency for research on cancerEpic sciencesRaindance technologies incBrandessence market researchBiopsy companiesPorter five forces analysis